MyFinsight
Home
Blog
About
Cash and cash
equivalents
$88,812K
(173.87%↑ Y/Y)
Prepaids and other
current assets
$2,428K
(69.43%↑ Y/Y)
Accounts receivable
$1,041K
(-69.37%↓ Y/Y)
Contract assets and
unbilled receivables...
$415K
(-64.77%↓ Y/Y)
Total current assets
$92,696K
(141.15%↑ Y/Y)
Property and equipment,
net
$172K
(-23.89%↓ Y/Y)
Restricted cash
$100K
Total assets
$92,968K
(140.44%↑ Y/Y)
Accumulated deficit
-$262,222K
(-69.60%↓ Y/Y)
Total liabilities,
convertible preferred stock...
$92,968K
(140.44%↑ Y/Y)
Total stockholders
(deficit) equity
-$12,986K
(-174.32%↓ Y/Y)
Additional paid-in capital
$249,228K
(44.83%↑ Y/Y)
Common stock, par value
0.0001 250,000,000 and...
$8K
(33.33%↑ Y/Y)
Total liabilities
$105,954K
(399.97%↑ Y/Y)
Warrant liabilities
$62,145K
(426.65%↑ Y/Y)
Long-term
debt-Nonrelated Party
$34,932K
Total current
liabilities
$7,605K
(-62.34%↓ Y/Y)
Long-term debt-Related
Party
$1,272K
Accrued expenses
$5,724K
(-17.37%↓ Y/Y)
Accounts payable
$1,881K
(28.40%↑ Y/Y)
Back
Back
Balance Sheet
Opus Genetics, Inc. (IRD)
Opus Genetics, Inc. (IRD)
source: myfinsight.com